We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
+33.27%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$273M
AUM Growth
+$22.8M
Cap. Flow
+$4.67M
Cap. Flow %
1.71%
Top 10 Hldgs %
26.58%
Holding
166
New
40
Increased
8
Reduced
21
Closed
31

Top Buys

Rank Stock Value
1
BLRX
BioLineRX
BLRX
+$5.92M
2
PLRX icon
Pliant Therapeutics
PLRX
+$4.11M
3
NSTG
NanoString Technologies, Inc.
NSTG
+$3.89M
4
RMD icon
ResMed
RMD
+$3.87M
5
BCAB icon
BioAtla
BCAB
+$3.62M

Top Sells

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$5.32M
2
LNTH icon
Lantheus
LNTH
+$3.48M
3
ESPR
Esperion Therapeutics
ESPR
+$3.45M
4
DXCM icon
DexCom
DXCM
+$3.28M
5
LIVN icon
LivaNova
LIVN
+$3.12M

Sector Composition

Rank Sector Weight
1 Healthcare 79.05%
2 Financials 10.08%
3 Industrials 0.61%
4 Consumer Staples 0.24%
5 Communication Services 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXH
76
DELISTED
Industrial Human Capital, Inc.
AXH
$1.01M 0.37%
100,000
– –
WAVSU
77
DELISTED
Western Acquisition Ventures Corp. Unit
WAVSU
$1.01M 0.37%
100,000
– –
RACYU
78
DELISTED
Relativity Acquisition Corp. Unit
RACYU
$1.01M 0.37%
100,000
– –
MURFU
79
DELISTED
Murphy Canyon Acquisition Corp. Unit
MURFU
$1M 0.37%
100,000
– –
BLSA
80
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$1M 0.37%
100,000
– –
OHAA
81
DELISTED
OPY Acquisition Corp. I Class A Common Stock
OHAA
$993K 0.36%
100,000
– –
OMEG
82
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$993K 0.36%
100,000
– –
ARYD
83
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$991K 0.36%
100,000
– –
AMLX icon
84
Amylyx Pharmaceuticals
AMLX
$2.54B
$985K 0.36%
+35,000
New +$873K
RCOR
85
DELISTED
Renovacor, Inc.
RCOR
$980K 0.36%
388,845
– –
JBIO
86
Jade Biosciences
JBIO
$1.34B
$846K 0.31%
+1,457
New +$973K
MITA
87
DELISTED
Coliseum Acquisition Corp. Class A Ordinary Share
MITA
$835K 0.31%
85,000
– –
CLNN icon
88
PUT
Clene
CLNN
$67.5M
$788K 0.29%
+14,075
New +$932K
POL.WS
89
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
$763K 0.28%
6,103,824
– –
RLMD icon
90
PUT
Relmada Therapeutics
RLMD
$527M
$674K 0.25%
+18,200
New +$504K
SDOT icon
91
Sadot Group
SDOT
$12.7M
$666K 0.24%
886
-12
-1% -$9.59K
DDI
92
DoubleDown Interactive
DDI
$588M
$562K 0.21%
60,876
– –
PALI icon
93
Palisade Bio
PALI
$367M
$559K 0.2%
+7,524
New +$1.59M
GSRMU
94
DELISTED
GSR II Meteora Acquisition Corp. Unit
GSRMU
$514K 0.19%
50,000
– –
PSQH icon
95
PSQ Holdings
PSQH
$14.7M
$488K 0.18%
3,333
– –
PEPG icon
96
PepGen
PEPG
$197M
$363K 0.13%
40,000
-40,000
-50% -$393K
TTOO
97
DELISTED
T2 Biosystems, Inc
TTOO
$321K 0.12%
+568
New +$374K
RLMD icon
98
Relmada Therapeutics
RLMD
$527M
$315K 0.12%
8,500
-19,500
-70% -$540K
WLDSW icon
99
Wearable Devices Ltd Warrant
WLDSW
$295K 0.11%
+1,961
New +$350K
AMLX icon
100
PUT
Amylyx Pharmaceuticals
AMLX
$2.54B
$253K 0.09%
9,000
-191,000
-96% -$4.77M
2 3
4
5 6

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return

Altium Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Altium Capital Management held 166 positions worth $273M, up 9.1% from $250M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Altium Capital Management's Q3 2022 filing shows 40 new, 8 increased, 21 reduced and 31 closed positions. Its largest new stake was BioLineRX: 103,732 shares worth $3.84M. The largest sale was STAAR Surgical, an estimated $5.32M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 74% a quarter earlier, followed by Financials and Industrials.

  • Altium Capital Management's largest Q3 2022 buy was BioLineRX: 103,732 shares worth $3.84M.
  • Altium Capital Management added most to AngioDynamics in Q3 2022, an estimated $3.41M increase.
  • Altium Capital Management's biggest Q3 2022 reduction was Lantheus, cutting an estimated $3.48M.
  • Altium Capital Management fully exited STAAR Surgical in Q3 2022, selling an estimated $5.32M.
  • Altium Capital Management's ten largest holdings make up 27% of its $273M portfolio in Q3 2022.
  • Altium Capital Management opened 40 new positions and closed 31 in Q3 2022.
  • Altium Capital Management's portfolio value rose 9.1% quarter-over-quarter to $273M.

Based on Altium Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.